» Articles » PMID: 11774071

Gdnf Haploinsufficiency Causes Hirschsprung-like Intestinal Obstruction and Early-onset Lethality in Mice

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 2002 Jan 5
PMID 11774071
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Hirschsprung disease (HSCR) is a common congenital disorder that results in intestinal obstruction and lethality, as a result of defective innervation of the gastrointestinal (GI) tract. Despite its congenital origin, the molecular etiology of HSCR remains elusive for >70% of patients. Although mutations in the c-RET receptor gene are frequently detected in patients with HSCR, mutations in the gene encoding its ligand (glial cell line-derived neurotrophic factor [GDNF]), are rarely found. In an effort to establish a possible link between human HSCR and mutations affecting the Gdnf locus, we studied a large population of mice heterozygous for a Gdnf null mutation. This Gdnf(+/-) mutant cohort recapitulates complex features characteristic of HSCR, including dominant inheritance, incomplete penetrance, and variable severity of symptoms. The lack of one functioning Gdnf allele causes a spectrum of defects in gastrointestinal motility and predisposes the mutant mice to HSCR-like phenotypes. As many as one in five Gdnf(+/-) mutant mice die shortly after birth. Using a transgenic marking strategy, we identified hypoganglionosis of the gastrointestinal tract as a developmental defect that renders the mutant mice susceptible to clinical symptoms of HSCR. Our findings offer a plausible way to link an array of seemingly disparate features characteristic of a complex disease to a much more narrowly defined genetic cause. These findings may have general implications for the genetic analysis of cause and effect in complex human diseases.

Citing Articles

Causes and consequences: development and pathophysiology of Hirschsprung disease.

Burns A, Goldstein A World J Pediatr Surg. 2024; 7(4):e000903.

PMID: 39600627 PMC: 11590806. DOI: 10.1136/wjps-2024-000903.


Cutting-edge regenerative therapy for Hirschsprung disease and its allied disorders.

Yoshimaru K, Matsuura T, Uchida Y, Sonoda S, Maeda S, Kajihara K Surg Today. 2023; 54(9):977-994.

PMID: 37668735 DOI: 10.1007/s00595-023-02741-6.


A Single RET Mutation in Hirschsprung Disease Induces Intestinal Aganglionosis Via a Dominant-Negative Mechanism.

Sunardi M, Ito K, Sato Y, Uesaka T, Iwasaki M, Enomoto H Cell Mol Gastroenterol Hepatol. 2022; 15(6):1505-1524.

PMID: 36521661 PMC: 10242352. DOI: 10.1016/j.jcmgh.2022.12.003.


Modification of Neurogenic Colonic Motor Behaviours by Chemogenetic Ablation of Calretinin Neurons.

Feng J, Hibberd T, Luo J, Yang P, Xie Z, Travis L Front Cell Neurosci. 2022; 16:799717.

PMID: 35317196 PMC: 8934436. DOI: 10.3389/fncel.2022.799717.


Generation of a Highly Biomimetic Organoid, Including Vasculature, Resembling the Native Immature Testis Tissue.

Cham T, Ibtisham F, Fayaz M, Honaramooz A Cells. 2021; 10(7).

PMID: 34359871 PMC: 8305979. DOI: 10.3390/cells10071696.


References
1.
Szabolcs M, Visser J, Shelanski M, OToole K, Schullinger J . Peripherin: a novel marker for the immunohistochemical study of malformations of the enteric nervous system. Pediatr Pathol Lab Med. 1996; 16(1):51-70. View

2.
Pasini B, Ceccherini I, Romeo G . RET mutations in human disease. Trends Genet. 1996; 12(4):138-44. DOI: 10.1016/0168-9525(96)10012-3. View

3.
Bedell M, Jenkins N, Copeland N . Mouse models of human disease. Part I: techniques and resources for genetic analysis in mice. Genes Dev. 1997; 11(1):1-10. DOI: 10.1101/gad.11.1.1. View

4.
Bedell M, Largaespada D, Jenkins N, Copeland N . Mouse models of human disease. Part II: recent progress and future directions. Genes Dev. 1997; 11(1):11-43. DOI: 10.1101/gad.11.1.11. View

5.
Kusafuka T, Puri P . Mutations of the endothelin-B receptor and endothelin-3 genes in Hirschsprung's disease. Pediatr Surg Int. 1997; 12(1):19-23. DOI: 10.1007/BF01194795. View